Business Context and Reporting Period
This Form 8-K filing by WellPoint, Inc. (now Elevance Health, Inc.) reports a corporate governance event dated February 20, 2013, with the report filed on February 22, 2013.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on executive appointments and does not contain financial performance data.
Material Changes
The primary material change is the appointment of Joseph R. Swedish to the Board of Directors and as Chief Executive Officer, effective March 25, 2013. Mr. Swedish was also appointed to the Executive Committee of the Board on the same effective date.
Guidance, Outlook, and Management Commentary
There is no financial guidance, outlook, or discussion of risks and contingencies in this filing. The document notes that Mr. Swedish will stand for re-election at the annual meeting of shareholders in May 2013. Regarding compensation, the filing states that as an executive officer, Mr. Swedish will not participate in the director compensation program but will receive compensation as set forth in the Offer Letter dated February 6, 2013.
Key Facts for Investor Verification
- Joseph R. Swedish was elected Director and appointed CEO effective March 25, 2013.
- Mr. Swedish's initial director term expires at the May 2013 annual shareholder meeting.
- Compensation details are contained in the Offer Letter filed as Exhibit 10.1 to a prior Form 8-K dated February 12, 2013.
- No relationships requiring disclosure under Item 404(a) of Regulation S-K exist between Mr. Swedish and the Company.